AtriCure scoops up fellow AF device maker nContact for cash and stock
AtriCure Inc. is paying $91mm in stock--issuing 3.7mm shares at $24.60 --and $8mm in cash to acquire closely held nContact Inc., which develops cardiac ablation devices.
- Medical Devices
Surgical Equipment & Devices
- Minimally or Less Invasive
- Surgical Equipment & Devices
- Full Acquisition
- Includes Contract
- Payment Includes Cash
- Payment Includes Stock
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.